The 340B program should never be about padding hospital profits — it should be about helping people like me live long enough ...

FDA’s public guidance continues to warn that, “under most circumstances,” importing drugs for personal use is unlawful, ...

In other countries, the government negotiates with pharmaceutical companies directly to set a single market price. In the U.S ...

Drug pricing, budget cuts, tariffs and other shifts under the Trump administration undermine the biopharma and healthcare ...

Donald Trump Jr. has joined billionaire entrepreneur Mark Cuban in publicly voicing disapproval of Sen. Elizabeth Warren ...

The Federal Trade Commission (FTC) and the Antitrust Division of the U.S. Department of Justice (DOJ), along with the U.S.

In early 2025, the White House renewed its push to lower prescription drug prices, part of an executive order aimed at easing patients' financial burdens. While the directive garnered headlines, many ...

Ahead of the launch, the firm has taken steps to amplify its production capacities to ensure adequate supply, and believes ...

While drug prices and insurance companies often draw scrutiny, the report shifts the spotlight to hospitals—particularly ...

Three months after the US Sofdra launch, prescriptions have exceeded Botanix Pharmaceuticals' expectations. What are they ...

A group of several businesses and organizations filed a lawsuit Monday challenging the new Iowa law putting regulations in place for pharmacy benefit managers, the companies negotiating prescription ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the ...